Lab-to-Lab Pardini
Lab-to-Lab Pardini operates a Brazilian B2B laboratory support network, enabling 8,000+ independent clinical laboratories to outsource specialized diagnostic examinations. The Grupo Fleury subsidiary processes 400M+ exams annually across 20 technical nuclei using its proprietary NTO Pardini automation platform and nationwide logistics.
- Company typePrivate
- Founded-
- HeadquartersBelo Horizonte, Brazil
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Lab-to-Lab Pardini does
Lab-to-Lab Pardini operates a B2B clinical laboratory support network that enables independent diagnostic laboratories across Brazil to outsource specialized and high-volume examinations. Founded in 1926 and headquartered in Vespasiano, Minas Gerais, the company is a subsidiary of Grupo Fleury, one of Brazil's largest diagnostic medicine groups. It serves over 8,000 partner laboratories through a fee-per-examination transaction model in which partners pay only for tests submitted for analysis, with no joining fee. Customers are predominantly small and mid-market clinical laboratories seeking to expand their test menus without investing in specialized equipment or expert staff, alongside adjacent segments in veterinary pathology and telemedicine.
Lab-to-Lab Pardini firmographics
Firmographics- Name
- Lab-to-Lab Pardini
- Legal name
- Lab to Lab Pardini
- Website
- https://labtolabpardini.com.br
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Lab-to-Lab Pardini operates a Brazilian B2B laboratory support network, enabling 8,000+ independent clinical laboratories to outsource specialized diagnostic examinations. The Grupo Fleury subsidiary processes 400M+ exams annually across 20 technical nuclei using its proprietary NTO Pardini automation platform and nationwide logistics.
- Ownership category
- akta.pro rank
Lab-to-Lab Pardini industry classification
Industry- Product category
- Laboratory Diagnostic Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
- akta.pro secondary industries
- Lab Middleware, Instrument Connectivity & Automation (HLACAMAI), Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery) (HLACAMAL), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Specimen Referral, Transport & Chain-of-Custody Coordination Networks (HLAJAIAO)
Keywords
Where Lab-to-Lab Pardini is headquartered
LocationHeadquarters
- HQ city
- Belo Horizonte
- HQ country
- Brazil
- HQ region
- Latin America
Offices3 records
Markets served
Lab-to-Lab Pardini business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Laboratory Support Services: Partner laboratories pay for examinations sent to Lab-to-Lab Pardini for analysis. There is no cost to become a partner - laboratories only invest in the examinations they send for analysis, with pricing passed on to their customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Partner Laboratory Model - No joining fee, pay-per-examination |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels8 records
Lab-to-Lab Pardini product offering
Product offeringCore offering
Lab-to-Lab Pardini is a B2B laboratory support network that processes clinical examinations on behalf of partner laboratories across Brazil. Partner labs send samples to Lab-to-Lab Pardini for analysis through the proprietary NTO Pardini automation platform, gaining access to 8,000+ examinations spanning clinical analysis, pathological anatomy, toxicology, genomics, telemedicine, and veterinary anatomy. Partner laboratories pay only for the examinations they submit, with no joining fee, while Lab-to-Lab Pardini handles specialized testing, logistics, and result delivery via the MyPardini digital platform.
Product overview
Lab-to-Lab Pardini is a laboratory support network operated as part of the Grupo Fleury ecosystem. The offering is structured as a platform-plus-services model centered on the MyPardini digital platform and the NTO Pardini automation hub, supplemented by a portfolio of seven service areas covering clinical analyses, lab supplies (Pardis), pathological anatomy, veterinary anatomy, toxicology, telemedicine, and genomics. Core enabling capabilities include integrated logistics serving over 2,000 municipalities, a customer service team, a help desk for exam guidance, and technical materials. The company processes over 400 million exams annually through 20 strategically located technical nuclei, serving more than 8,000 partner laboratories.
Differentiator
Problem solved
Functional benefit
Brands
- NTO Pardini: Núcleo Técnico Operacional - the company's advanced laboratory automation facility, described as the most advanced in the world.
- MyPardini
- Mundo Lab-to-Lab
- Pardis
Quantifiable outcome
- 85% of tests processed within 6 hours
- +3 more outcomes
Companies that use Lab-to-Lab Pardini
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Lab-to-Lab Pardini technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Lab-to-Lab Pardini partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Grupo FleurycoreLab-to-Lab Pardini is part of the Grupo Fleury ecosystem, one of Brazil's healthcare leaders. Grupo Fleury provides quality standards, brand credibility, and operational expertise to Lab-to-Lab Pardini, enabling access to complete, integrated, and sustainable healthcare solutions.
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Lab-to-Lab Pardini competitors and assessment
Company assessmentDirect peers
- Sabin Medicina Diagnóstica: Major Brazilian clinical diagnostics network with nationwide presence. Competes for partner lab business and high-complexity testing referrals, particularly in central Brazil.
- DASA (Diagnósticos da América): Brazil's largest diagnostics company, operating a broad network of clinical laboratories and active in reference/outsourced lab services. Directly competes with Lab-to-Lab Pardini for partner lab volume and high-complexity testing across Brazil.
- Hermes Pardini: Brazilian reference and specialty diagnostics laboratory with strong presence in genomic and high-complexity testing. Closely comparable to Pardini's partner-lab reference services and specialty test menu.
Broad incumbents
- Eurofins Scientific: Global laboratory testing services group covering clinical diagnostics, food, environment, and pharma. Comparable as a high-volume reference lab operator with broad test menus across multiple verticals.
- Sonic Healthcare: Global medical diagnostics leader with extensive reference laboratory operations across multiple geographies. Highly comparable to Lab-to-Lab Pardini's B2B reference lab business model and menu breadth.
- Quest Diagnostics: U.S. clinical laboratory services leader providing routine and specialty testing, including reference lab services. Comparable to Pardini in operational scale, test menu breadth, and automation investment.
- Grupo Fleury: Parent company of Lab-to-Lab Pardini and one of Brazil's leading diagnostic medicine providers. Operates a broad portfolio of clinical labs, hospitals, and outpatient services that overlap with — and potentially compete with — the Pardini partner channel.
- Synlab: European leader in medical diagnostic services, operating a network of reference and clinical laboratories. Comparable in scale, reference lab model, and broad test menu to Pardini's platform.
Regional players
- SRL Diagnostics: India's largest diagnostic laboratory network with strong reference lab capabilities. Comparable in B2B partner model and high-volume test processing, though operating in a different geography.
- Dr. Lal PathLabs: Leading Indian diagnostic chain with extensive reference lab operations and broad test menu. Comparable in scale, automation platform, and partner-driven growth strategy, though geographically focused in India.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Lab-to-Lab Pardini social profiles
Digital presenceLab-to-Lab Pardini financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lab-to-Lab Pardini leadership team
Management profileNumber of profiles
Lab-to-Lab Pardini funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lab-to-Lab Pardini M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lab-to-Lab Pardini
What does Lab-to-Lab Pardini do?
Lab-to-Lab Pardini is a B2B laboratory support network that processes clinical examinations on behalf of partner laboratories across Brazil. Partner labs send samples to Lab-to-Lab Pardini for analysis through the proprietary NTO Pardini automation platform, gaining access to 8,000+ examinations spanning clinical analysis, pathological anatomy, toxicology, genomics, telemedicine, and veterinary anatomy. Partner laboratories pay only for the examinations they submit, with no joining fee, while Lab-to-Lab Pardini handles specialized testing, logistics, and result delivery via the MyPardini digital platform.
Is Lab-to-Lab Pardini a public or private company?
Lab-to-Lab Pardini is a private company. It is classified as corporate owned and is currently operating.
When was Lab-to-Lab Pardini founded?
Lab-to-Lab Pardini was founded in -1. It employs 1,001 to 5,000 people.
Where is Lab-to-Lab Pardini based?
Lab-to-Lab Pardini is headquartered in Belo Horizonte, Brazil, in the Latin America region.
How does Lab-to-Lab Pardini make money?
One revenue line is on record: laboratory Support Services.
Who are Lab-to-Lab Pardini's main competitors?
Direct peers on record are Sabin Medicina Diagnóstica, DASA (Diagnósticos da América) and Hermes Pardini. Broad incumbents are Eurofins Scientific, Sonic Healthcare, Quest Diagnostics, Grupo Fleury and Synlab. Regional players are SRL Diagnostics and Dr. Lal PathLabs.
Does Lab-to-Lab Pardini have an API?
No public API is recorded for Lab-to-Lab Pardini.
What industry is Lab-to-Lab Pardini in?
Lab-to-Lab Pardini's product category is Laboratory Diagnostic Services. Its primary akta.pro industry code is HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories, with a secondary code of HLACAMAI, Lab Middleware, Instrument Connectivity & Automation. Its NAICS code is 621511 and its SIC code is 8071.